Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma

NCT00693433

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Veteran's Administration Medical Center Las Angeles, California, United States

View Trial Details

Completed

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

NCT00083551

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States

View Trial Details

Completed

Geriatric Assessments in Senior Adults With Multiple Myeloma

NCT01746030

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

B-Receptor Signaling in Cardiomyopathy

NCT01135849

Conditions: Adenocarcinoma, Adenoma, Amyloidosis, +140 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT

NCT01691300

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Chang Gung Memorial Hostpial Guishan, Taoyuan county, Taiwan

View Trial Details

Completed

Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy

NCT00002850

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: MBCCOP - Gulf Coast Mobile, Alabama, United States

Mobile Infirmary Medical Center Mobile, Alabama, United States

Cedar Rapids Oncology Associates Cedar Rapids, Iowa, United States

McCreery Cancer Center at Ottumwa Regional Ottumwa, Iowa, United States

View all 45 locations

View Trial Details

Completed

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

NCT00161187

Conditions: Adenocarcinoma, Adnexal Diseases, Blast Crisis, +151 more
Locations: Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States

View Trial Details

Completed

Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma

NCT00103506

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Alabaster, Alabama, United States

Surprise, Arizona, United States

Berkeley, California, United States

Loma Linda, California, United States

View all 108 locations

View Trial Details

Completed

UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma

NCT01621672

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Arkansas for Medical Science-MIRT Little Rock, Arkansas, United States

View Trial Details

Completed

Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma

NCT00276536

Conditions: Blood Protein Disorders, Breast Cancer, Breast Diseases, +40 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Hemostatic Disorders

Hemostatic Disorders trial results

Related conditions